Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2026-01-12

FDA Approved: FLUTICASONE PROPIONATE AND SALMETEROL — Original Application (Lannett Company, Inc.)

View source ↗

Summary

FDA approved a generic version of the fluticasone propionate and salmeterol inhalation product (Lannett) under an original ANDA, for maintenance treatment in as…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fluticasone Propionate and Salmeterol (Fluticasone Propionate and Salmeterol)

Snippet

ORIG AP for FLUTICASONE PROPIONATE AND SALMETEROL (FLUTICASONE PROPIONATE AND SALMETEROL)